Analysis of humoral and cellular immunity after SARS-CoV-2 vaccination in patients with multiple sclerosis treated with immunomodulatory drugs
We analyzed immune response to SARS-CoV-2 vaccination by measuring specific IgG titers and T-cell reactivity to different SARS-CoV-2 peptides in multiple sclerosis patients taking different disease-modifying treatments. Of the 88 patients included, 72 developed any kind of immune response after vacc...
Main Authors: | Virginia Meca-Lallana, Laura Esparcia-Pinedo, Clara Aguirre, Carolina Díaz-Pérez, Ainhoa Gutierrez-Cobos, Mónica Sobrado, Estefanía Carabajal, Beatriz del Río, Noelia Ropero, Ramón Villagrasa, José Vivancos, Francisco Sanchez-Madrid, Arantzazu Alfranca |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-12-01
|
Series: | Clinical Immunology Communications |
Online Access: | http://www.sciencedirect.com/science/article/pii/S277261342300001X |
Similar Items
-
Tertiary lymphoid structures and B lymphocytes: a promising therapeutic strategy to fight cancer
by: Laura Esparcia-Pinedo, et al.
Published: (2023-08-01) -
CD4+ T Cell Immune Specificity Changes After Vaccination in Healthy And COVID-19 Convalescent Subjects
by: Laura Esparcia-Pinedo, et al.
Published: (2022-01-01) -
Humoral Response to SARS-COV-2 Vaccination in Patients with Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder: A Real-World Study
by: Jorge Millán-Pascual, et al.
Published: (2023-12-01) -
Immunomodulatory effects of pneumococcal extracellular vesicles on cellular and humoral host defenses
by: Codemo, Mario, et al.
Published: (2019) -
The immunomodulatory phenomenon of vitamin D in the pathogenesis of Multiple Sclerosis
by: Karolina Raksa, et al.
Published: (2023-03-01)